Rapaflo (silodosin), a new selective alpha-blocker for benign prostatic hyperplasia (BPH)
February 2012
Reps will promote Rapaflo (silodosin), a new selective alpha-blocker for benign prostatic hyperplasia (BPH).
Rapaflo is more selective for alpha-receptors that relax the bladder and prostate...compared to those that lower blood pressure.
This causes less dizziness and hypotension than older and less selective alpha-blockers (terazosin, etc)...but more abnormal ejaculation. Relaxing the bladder can cause semen to go backwards into the bladder during ejaculation.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive